IMMUNOGLOBULIN G1, ANTI-(HUMAN MESOTHELIN) (HUMAN MONOCLONAL MF-T-IGG1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MF-T-IGG1 .LAMBDA.-CHAIN, DIMER, N6-(4-((4-(3-(BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)-2-((BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)METHYL)PROPYL)PHENYL)AMINO)-1,4-DIOXOBUTYL)-L-LYSINE COMPLEX WITH THORIUM-227TH
Advanced Recurrent Serous Ovarian Cancer
Bayerantibody_drug_conjugatePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
115 Active assets in the Advanced Recurrent Serous Ovarian Cancer cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Carboplatin National Cancer Institute (NCI) | Phase 3 | BBB |
Olaparib Institute of Cancer Research, United Kingdom | Phase 3 | BB |
Inno-206 National Cancer Institute (NCI) | Phase 3 | BB |
Olaparib National Cancer Institute (NCI) | Phase 2/3 | BB |
Letrozole Memorial Sloan Kettering Cancer Center | Phase 3 | BB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1, ANTI-(HUMAN MESOTHELIN) (HUMAN MONOCLONAL MF-T-IGG1 HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL MF-T-IGG1 .LAMBDA.-CHAIN, DIMER, N6-(4-((4-(3-(BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)-2-((BIS(2-(((1,2-DIHYDRO-3-(HYDROXY-.KAPPA.O)-1-METHYL-2-(OXO-.KAPPA.O)-4-PYRIDINYL)CARBONYL)AMINO)ETHYL)AMINO)METHYL)PROPYL)PHENYL)AMINO)-1,4-DIOXOBUTYL)-L-LYSINE COMPLEX WITH THORIUM-227TH is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →